The role of B-cells and IgM antibodies in parasitemia, anemia, and VSG switching in Trypanosoma brucei-infected mice

PLoS Pathogens

Volumn 4, Issue 8, 2008, Pages

  Magez, Stefan ^a,b,c,d   Schwegmann, Anita ^a,b   Atkinson, Robert ^a,b   Claes, Filip ^e   Drennan, Michael ^a,b,c   De Baetselier, Patrick ^c,d   Brombacher, Frank ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^e INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; IMMUNOGLOBULIN M ANTIBODY; PARASITE ANTIGEN; UNCLASSIFIED DRUG; VARIANT SPECIFIC SURFACE GLYCOPROTEIN; IMMUNOGLOBULIN M; PROTOZOON ANTIBODY;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGENIC VARIATION; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL MOUSE; FEMALE; GENE SWITCHING; IMMUNE RESPONSE; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITEMIA; SURVIVAL; TRYPANOSOMA; TRYPANOSOMA BRUCEI; TRYPANOSOMIASIS; AFRICAN TRYPANOSOMIASIS; ANIMAL; BAGG ALBINO MOUSE; GENETICS; IMMUNOLOGY; MOUSE MUTANT; PARASITOLOGY; PATHOLOGY; PATHOPHYSIOLOGY;

GLOSSINA (GENUS); MAMMALIA; MURINAE; MUS; PROTOZOA; TRYPANOSOMA BRUCEI;

ANEMIA; ANIMALS; ANTIBODIES, PROTOZOAN; B-LYMPHOCYTES; FEMALE; IMMUNOGLOBULIN M; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PARASITEMIA; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN;

EID: 50849133896     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000122     Document Type: Article

References (44)

1. Vickerman K (1985) Developmental cycles and biology of pathogenic trypanosomes. Br Med Bull 41: 105-114.
2. WHO (1998) Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 881: I-VI, 1-114.
3. Van den Bossche P (2001) Some general aspects of the distribution and epidemiology of bovine trypanosomosis in southern Africa. Int J Parasitol 31: 592-598.
4. van Meirvenne N (1999) Biological diagnosis of human African trypanosomiasis. Progress in human African trypanosomiasis, sleeping sickness. Paris ; London: Springer. pp 235-252.
5. Vanhamme L, Pays E, McCulloch R, Barry JD (2001) An update on antigenic variation in African trypanosomes. Trends Parasitol 17: 338-343.
6. Borst P (2002) Antigenic variation and allelic exclusion. Cell 109: 5-8.
7. Pays E, Tebabi P, Pays A, Coquelet H, Revelard P, et al. (1989) The genes and transcripts of an antigen gene expression site from T. brucei. Cell 57: 835-845.
8. Reinitz DM, Mansfield JM (1990) T-cell-independent and T-cell-dependent Bcell responses to exposed variant surface glycoprotein epitopes in trypanosome-infected mice. Infect Immun 58: 2337-2342.
9. Campbell GH, Esser KM, Weinbaum FI (1977) Trypanosoma rhodesiense infection in B-cell-deficient mice. Infect Immun 18: 434-438.
10. de Gee AL, McCann PP, Mansfield JM (1983) Role of antibody in the elimination of trypanosomes after DL-alpha-difluoromethylornithine chemotherapy. J Parasitol 69: 818-822.
11. Guirnalda P, Murphy NB, Nolan D, Black SJ (2007) Anti-Trypanosoma brucei activity in Cape buffalo serum during the cryptic phase of parasitemia is mediated by antibodies. Int J Parasitol 37: 1391-1399.
12. Naessens J, Leak SG, Kennedy DJ, Kemp SJ, Teale AJ (2003) Responses of bovine chimaeras combining trypanosomosis resistant and susceptible genotypes to experimental infection with Trypanosoma congolense. Vet Parasitol 111: 125-142.
13. Matthews KR (1999) Developments in the differentiation of Trypanosoma brucei. Parasitol Today 15: 76-80.
14. Black SJ, Sendashonga CN, O'Brien C, Borowy NK, Naessens M, et al. (1985) Regulation of parasitaemia in mice infected with Trypanosoma brucei. Curr Top Microbiol Immunol 117: 93-118.
15. Savill NJ, Seed JR (2004) Mathematical and statistical analysis of the Trypanosoma brucei slender to stumpy transition. Parasitology 128: 53-67.
16. Amole BO, Clarkson AB Jr, Shear HL (1982) Pathogenesis of anemia in Trypanosoma brucei-infected mice. Infect Immun 36: 1060-1068.
17. Mabbott NA, Coulson PS, Smythies LE, Wilson RA, Sternberg JM (1998) African trypanosome infections in mice that lack the interferon-gamma receptor gene: nitric oxide-dependent and -independent suppression of T-cell proliferative responses and the development of anaemia. Immunology 94: 476-480.
18. Magez S, Radwanska M, Beschin A, Sekikawa K, De Baetselier P (1999) Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections. Infect Immun 67: 3128-3132.
19. Cox FE (1979) Pathogenesis of animal trypanosomiasis. Nature 277: 603-604.
20. Murray M, Dexter TM (1988) Anaemia in bovine African trypanosomiasis. A review. Acta Trop 45: 389-432.
21. Ouma J, Mwangi J, Mdachi R, Njiru Z, Ndung' U (2001) Validation of indirect Elisa systems for the serodiagnosis of bovine Trypanosomosis in endemic areas of Kenya. FAO/IAEA report. In Animal Trypanosomosis: diagnosis and epidemiology. Leiden, The Netherlands: Backhuys Publishers. pp 93-97.
22. Dumas M, Bisser S (1999) Clinical aspects of human African trypanosomiasis. In Progress in human African trypanosomiasis, sleeping sickness. Paris ; London: Springer. pp 215-252.
23. Rifkin MR, Landsberger FR (1990) Trypanosome variant surface glycoprotein transfer to target membranes: a model for the pathogenesis of trypanosomiasis. Proc Natl Acad Sci U S A 87: 801-805.
24. Tizard IR, Holmes WL, Nielsen K (1978) Mechanisms of the anemia in trypanosomiasis: studies on the role of the hemolytic fatty acids derived from Trypanosoma congolense. Tropenmed Parasitol 29: 108-114.
25. Kitamura D, Roes J, Kuhn R, Rajewsky K (1991) A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350: 423-426.
26. Lutz C, Ledermann B, Kosco-Vilbois MH, Ochsenbein AF, Zinkernagel RM, et al. (1998) IgD can largely substitute for loss of IgM function in B cells. Nature 393: 797-801.
27. Radwanska M, Magez S, Michel A, Stijlemans B, Geuskens M, et al. (2000) Comparative analysis of antibody responses against HSP60, invariant surface glycoprotein 70, and variant surface glycoprotein reveals a complex antigen-specific pattern of immunoglobulin isotype switching during infection by Trypanosoma brucei. Infect Immun 68: 848-860.
28. Herbert DR, Holscher C, Mohrs M, Arendse B, Schwegmann A, et al. (2004) Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20: 623-635.
29. O'Beirne C, Lowry CM, Voorheis HP (1998) Both IgM and IgG anti-VSG antibodies initiate a cycle of aggregation-disaggregation of bloodstream forms of Trypanosoma brucei without damage to the parasite. Mol Biochem Parasitol 91: 165-193.
30. Sendashonga CN, Black SJ (1982) Humoral responses against Trypanosoma brucei variable surface antigen are induced by degenerating parasites. Parasite Immunol 4: 245-257.
31. Dempsey WL, Mansfield JM (1983) Lymphocyte function in experimental African trypanosomiasis. V. Role of antibody and the mononuclear phagocyte system in variant-specific immunity. J Immunol 130: 405-411.
32. Black SJ, Sicard EL, Murphy N, Nolan D (2001) Innate and acquired control of trypanosome parasitaemia in Cape buffalo. Int J Parasitol 31: 562-565.
33. Horn D, Cross GA (1997) Analysis of Trypanosoma brucei vsg expression site switching in vitro. Mol Biochem Parasitol 84: 189-201.
34. Williams DJ, Taylor K, Newson J, Gichuki B, Naessens J (1996) The role of antivariable surface glycoprotein antibody responses in bovine trypanotolerance. Parasite Immunol 18: 209-218.
35. Witola WH, Lovelace CE (2001) Demonstration of erythrophagocytosis in Trypanosoma congolense-infected goats. Vet Parasitol 96: 115-126.
36. Naessens J, Kitani H, Nakamura Y, Yagi Y, Sekikawa K, et al. (2005) TNF-alpha mediates the development of anaemia in a murine Trypanosoma brucei rhodesiense infection, but not the anaemia associated with a murine Trypanosoma congolense infection. Clin Exp Immunol 139: 405-410.
37. Sileghem M, Flynn JN, Logan-Henfrey L, Ellis J (1994) Tumour necrosis factor production by monocytes from cattle infected with Trypanosoma (Duttonella) vivax and Trypanosoma (Nannomonas) congolense: possible association with severity of anaemia associated with the disease. Parasite Immunol 16: 51-54.
38. Branch DR, Guilbert LJ (1996) Autocrine regulation of macrophage proliferation by tumor necrosis factor-alpha. Exp Hematol 24: 675-681.
39. Collins HL, Bancroft GJ (1992) Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur J Immunol 22: 1447-1454.
40. Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ (1997) Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 100: 1969-1979.
41. Hertz CJ, Filutowicz H, Mansfield JM (1998) Resistance to the African trypanosomes is IFN-gamma dependent. J Immunol 161: 6775-6783.
42. Tabel H, Kaushik RS, Uzonna JE (2000) Susceptibility and resistance to Trypanosoma congolense infections. Microbes Infect 2: 1619-1629.
43. Inoue N, Narumi D, Mbati PA, Hirumi K, Situakibanza NT, et al. (1998) Susceptibility of severe combined immuno-deficient (SCID) mice to Trypanosoma brucei gambiense and T. b. rhodesiense. Trop Med Int Health 3: 408-412.
44. Reuner B, Vassella E, Yutzy B, Boshart M (1997) Cell density triggers slender to stumpy differentiation of Trypanosoma brucei bloodstream forms in culture. Mol Biochem Parasitol 90: 269-280.